Teon Therapeutics Completes $30 Million Series A Financing

SAN FRANCISCO, Feb. 23, 2021 /PRNewswire/ -- Teon Therapeutics, a biopharmaceutical company developing small molecules that inhibit the immunosuppressive and cancer-promoting signaling pathways, today announced the completion of a $30M Series A financing. The financing was led by...